Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsCAPSULEGeneric

PALBOCICLIB CAPSULES

PALBOCICLIB

Standard Dose
125MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview PALBOCICLIB CAPSULES is listed in Drugs@FDA under application 217365 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient PALBOCICLIB Form and strength CAPSULE - 125MG Sponsor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

Structured Monograph

Clinical summary

Approval overview PALBOCICLIB CAPSULES is listed in Drugs@FDA under application 217365 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient PALBOCICLIB Form and strength CAPSULE - 125MG Sponsor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. Submission history Latest submission status date: 2025-11-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.